Why Does Immunotherapy Not Benefit Everyone Long-term?
Immunotherapy is revolutionizing the treatment of cancer. As discussed in an earlier post on this blog, immunotherapeutics that work...
Immunotherapy is revolutionizing the treatment of cancer. As discussed in an earlier post on this blog, immunotherapeutics that work...
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
In the fall issue, Cancer Today had the honor of highlighting two women whose cancer diagnoses led them to...
Philadelphia Eagles player Rodney McLeod he has looked to honor his grandmother’s memory by supporting the American Association for...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...
Just days before the start of multiple myeloma awareness month, which began Sunday, March 1, the U.S. Food and...
This past week has included good news for some patients with lung cancer and bad news for those with...
The human microbiome – the collection of bacteria, viruses, fungi, and other microorganisms that live inside and on the...
As the temperature soared this summer, the laps around the park became harder to endure. When her skin chafed...
Every September 24, World Cancer Research Day provides an opportunity to raise awareness about the important role research plays...
Attendees gathered firsthand information on all things breast cancer during the five-day San Antonio Breast Cancer Symposium, which showcased...
The San Antonio Breast Cancer Symposium (SABCS), which marks its 40th anniversary this year, has become the world's premier...
A highly complex filtering system, the kidneys process roughly half a cup of blood every minute, isolating waste and...
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
In recent decades, the cancer research community has made great strides by bringing new, targeted, safer, and longer-lasting treatments...
Today, the American Association for Cancer Research (AACR) released its sixth annual Cancer Progress Report. The report highlights how...
Today, the American Association for Cancer Research (AACR) released its seventh annual Cancer Progress Report. The report highlights how...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....
Women have played many pivotal roles at the American Association for Cancer Research (AACR), from the organization’s earliest years...
The U.S. Latino population surged 243 percent from 1980 to 2010. But in the same time span, the Latino...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
A recent estimate suggests that more than 40 percent of cancers could be prevented. Modifiable factors linked to cancer...
On Sunday, almost 300 of the greatest minds in ovarian cancer research will come together in Pittsburgh to discuss...
Dr. Alan D’Andrea spoke about a new grant looking for fresh perspectives in Fanconi anemia-related cancer research.
The American Association for Cancer Research (AACR) has released its 2015 Annual Report, titled “Bringing Cancer Discoveries to Patients.”...
Three patients share their experiences about having Lynch syndrome.
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
Insights from the AACR Cancer Disparities Progress Report 2024.